Physician and cancer researcher Marián Hajdúch, head of the Institute of Molecular and Translational Medicine, recalled Kellner’s investments into science: “Among other things, Petr Kellner was one of the first investors in biomedicine & biotechnology in the Czech Republic. He founded the firm Sotio, stimulated the interest of a number of other investors in the results of academic research, thus contributing to the development of this promising industry. Sincere condolences to the family. R.I.P.” The pharmaceutical firm Sotio develops cancer treatments.